Real-world evidence in the management of type 2 diabetes: switching from other DPP‑4 inhibitors to alogliptin (Vipidia®)
This promotional educational webinar has been organised and funded by Takeda UK Ltd. See bottom of page for full disclaimer.
NICE guidance on respiratory conditions and COVID-19: 5-minute video
Dr Kevin Gruffydd-Jones highlights important things you need to know about managing respiratory conditions in a COVID-19 context
Death certification in COVID-19: 5-minute video
Dr Toni Hazell highlights important things you need to know about changes to death certification processes during the COVID-19 outbreak
Secondary event prevention and risk stratification in patients with symptomatic peripheral arterial disease (PAD)
Information intended for healthcare professionals only. The development of this Guidelines in Practice video has been commissioned by Bayer plc. Please see the bottom of the page for full disclaimer.
Secondary event prevention and risk stratification in patients with stable coronary artery disease (CAD)
Information intended for healthcare professionals only. The development of this Guidelines in Practice video has been commissioned by Bayer plc. Please see the bottom of the page for full disclaimer.
Implementing the clinical guideline on pancreatic exocrine insufficiency in diabetes
Supported by an arm’s-length educational grant from Mylan.
Implementing the Primary Care Dermatology Society guideline and primary care treatment pathway for actinic (solar) keratosis
Information intended for healthcare professionals only. Guidelines in Practice approached Almirall Ltd for an educational grant to support the production of an implementation checklist. Please see the bottom of the page for full disclaimer.
Amgevita® ▼ (adalimumab biosimilar)
This formulary discussion guide was developed from content provided by Amgen Ltd in a format developed by Guidelines in Practice.
Case study on Type 2 diabetes management: implementation of a DPP-4 inhibitor switch strategy across a primary care network
This advertorial has been commissioned and developed by Takeda UK Ltd.
Respimat® Soft Mist™ reusable inhaler: patient benefits and environmental impact
This animation has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines in Practice. Boehringer Ingelheim Ltd suggested the topic and the presenter, and carried out full medical approval on all materials to ensure compliance with regulations. The sponsorship fee included an honorarium for the ...
Fencino® (fentanyl transdermal patch): clinical and practical considerations
This animation has been commissioned and funded by Ethypharm UK Ltd and developed in partnership with Guidelines in Practice. Ethypharm UK Ltd suggested the topic and the presenter, and carried out full medical approval on all materials to ensure compliance with regulations. The sponsorship fee included an honorarium for the ...
Cost-benefit of prescribing emollients for eczema patients
The content of this infographic has been developed by Johnson & Johnson Ltd.